Skip to main content
Michael J. Metro

Michael J. Metro

🇺🇸 United States🏥 Jefferson HealthMD
Mentored by · fellowship 2002
Jack W. McAninch

Training and career​

  • Current position Reconstructive urologist, Jefferson Health, Philadelphia12
  • Previous position Director of reconstructive urology, Temple University Hospital, Philadelphia34
  • Medical school University of Pittsburgh1
  • Residency Urology, Hospital of the University of Pennsylvania1
  • Fellowship Male genitourinary reconstruction and trauma, University of California, San Francisco (2001–2002)4
  • Fellows trained Eight reconstructive fellows (2018–2026) are listed under him in the GURS fellowship tree5

Key Publications​

Metro's cited work covers Peyronie's disease plication outcomes, robotic buccal mucosa graft ureteroplasty and the SIU/ICUD consultation on lichen sclerosus urethral stricture.P1P2P3

  1. Ly L, Christianson SS, Taylor LC, Dunphy M, Morales-Lopez R, Douglass L, Metro M. "Functional penile length after penile plication: 'empha-sizing' what matters." Urology. 2023;172:210–212. doi

    Functional penile length after plication (2023). Senior author of a series of 28 men with Peyronie's disease in which functional penile length, measured on the erect penis from pubis to glans tip, rose from 11.1 cm before plication to 12.5 cm after correction.

  2. Lee Z, Waldorf BT, Cho EY, Liu JC, Metro MJ, Eun DD. "Robotic ureteroplasty with buccal mucosa graft for the management of complex ureteral strictures." J Urol. 2017;198(6):1430–1435. doi

    Robotic ureteroplasty with buccal mucosa graft (2017). Coauthored the Temple series of 12 proximal or mid ureteral strictures not suited to excision and anastomosis; 10 (83%) were clinically and radiologically successful at a median follow-up of 13 months.

  3. Stewart L, McCammon K, Metro M, Virasoro R. "SIU/ICUD consultation on urethral strictures: anterior urethra—lichen sclerosus." Urology. 2014;83(3 Suppl):S27–S30. doi

Footnotes​

  1. Michael J Metro, MD. Jefferson Health. Accessed October 2026. ↩ ↩2 ↩3

  2. Metro MJ. "Reply to editorial comment on 'Still ROBUST: a retrospective study of Optilume drug-coated balloon dilation for complex urethral stricture disease'." Urology. Published online September 10, 2026. doi:10.1016/j.urology.2026.09.004 (author affiliation: Jefferson Health System, Philadelphia) ↩

  3. Michael Metro, MD. Temple Health Physician Resources (archived January 2025). Accessed October 2026. ↩

  4. Where are our fellows now? Department of Urology, University of California, San Francisco. Accessed October 2026. ↩ ↩2

  5. GURS Fellowship Tree. Lee Zhao, NYU Langone. Accessed October 2026. ↩